Net income rose to $11.1 million and adjusted EBITDA rose to $32.3 million
Patients should be educated on hypoglycemia recognition and management
Naltrexone doesnt erase the routines, emotions, or environments associated with drinking, but it can make those patterns easier to change as you build new habits
By normalizing hunger signaling and reducing compulsive eating urges, patients gain better control over eating behaviors previously experienced as involuntary
Patients taking GLP-1 drugs lose weight faster, but they may experience side effects, such as nausea, vomiting, diarrhea, indigestion, fatigue, dizziness, and hypoglycemia, along with other potential adverse events